Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. 利用即時定量PCR方法偵測急性骨髓性白血病病人治療前後之微量殘存腫瘤細胞(2/2)
 
  • Details

利用即時定量PCR方法偵測急性骨髓性白血病病人治療前後之微量殘存腫瘤細胞(2/2)

Date Issued
2002
Date
2002
Author(s)
唐季祿
DOI
902314B002244
URI
http://ntur.lib.ntu.edu.tw//handle/246246/23555
Abstract
The 8;21 translocation is one of common karyotype abnormalities in acute myeloid leukemia (AML). AML1 and ETO gene were fused in t(8;21) and can be consistently detected by RT-PCR. In this study, therapeutic monitoring of minimal residual disease (MRD) using a novel, quantitative, real-time RT-PCR was evaluated in AML with t(8;21) as a model. A t(8;21)-positive cell line, Kasumi-1, was used for constructing standard curves and the corrected AML1-ETO mRNA level relative to the expression of the GAPDH housekeeping gene was calculated. At optimal condition, this assay yield an excellent log-linear relationship of PCR threshold cycle number (CT) with wide-range of initial target mRNA concentration (correlation of coefficient, r > 0.99, n=13) and sensitivity of detecting MRD as low as 10 -5 level. Sequential measurement of AML1-ETO level was performed in 40 t(8;21)-positive patients and correlated with their clinical outcome. At diagnosis, the AML1-ETO levels ranged between 0.26~1.45-fold compared with Kasumi-1 standard. Those patients with MRD level > 10 -2 after induction therapy and/or > 10 -3 after 1-2 courses of consolidation therapy had higher risk of leukemic relapse, even treated with high-dose Ara-C or bone marrow transplant (BMT). Those patients failed to achieve MRD level < 10 -4 within 6 months after BMT eventually relapsed unless chronic graft-versus host disease occurred in time. No residual MRD (i.e. less than 10 -5 ) was detectable in 9 patients in continued remission > 2 years. These data suggest that this simple and sensitive assay is very useful in therapeutic monitoring of AML treatment, in identifying high-risk patients, and in early detection of leukemic relapse.
Subjects
real-time PCR
quantitation
minimal residual disease
acute
myeloid leukemia
Publisher
臺北市:國立臺灣大學醫學院內科
Type
report
File(s)
Loading...
Thumbnail Image
Name

902314B002244.pdf

Size

678.46 KB

Format

Adobe PDF

Checksum

(MD5):cb877eb40791d7630c8d15c210449885

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science